SeekingAlpha News Releases and Press Releases From 07/20/24

2024-07-20 09:37:01 ET Summary 4D Molecular Therapeutics' share price fell by over 15% in response to its latest data readout related to Wet-AMD therapy 4D-150. Investors reacted negatively to the news, which may be surprising as it seemed to confirm a positive treatment effect an...

2024-07-20 09:30:00 ET Summary The REIT sector being down over the past 2 years created buying opportunities not only for investors, but for management teams (insiders) as well. Insider buying in REITs like Agree Realty and Armada Hoffler Properties indicates the REITs could be po...

2024-07-20 09:30:00 ET Summary The REIT sector being down over the past 2 years created buying opportunities not only for investors, but for management teams (insiders) as well. Insider buying in REITs like Agree Realty and Armada Hoffler Properties indicates the REITs could be po...

2024-07-20 09:30:00 ET Summary The REIT sector being down over the past 2 years created buying opportunities not only for investors, but for management teams (insiders) as well. Insider buying in REITs like Agree Realty and Armada Hoffler Properties indicates the REITs could be po...

2024-07-20 09:30:00 ET Summary The REIT sector being down over the past 2 years created buying opportunities not only for investors, but for management teams (insiders) as well. Insider buying in REITs like Agree Realty and Armada Hoffler Properties indicates the REITs could be po...

2024-07-20 09:24:27 ET Summary Choice Properties REIT reported a strong Q2'24 in line with expectations. The REIT renewed the vast majority of next year's Loblaw lease expiries at higher net rents per square foot and achieved double-digit retail lease renewal rent spreads this qua...

2024-07-20 09:24:27 ET Summary Choice Properties REIT reported a strong Q2'24 in line with expectations. The REIT renewed the vast majority of next year's Loblaw lease expiries at higher net rents per square foot and achieved double-digit retail lease renewal rent spreads this qua...

2024-07-20 09:23:19 ET Summary Annaly Capital's portfolio has had a tough couple of years, but cyclical opportunity may be ahead. Members of the Fed have given clearer signs that rate cuts are on the way, which benefit a portfolio like Annaly's. Yet the current price suggests ...

2024-07-20 09:20:25 ET Summary VKTX's obesity therapy candidate, VK2735, demonstrates accelerated weight loss results compared to Wegovy/ Mounjaro and the next-gen candidates, including CagriSema/ Zepbound/ Retatrutide. This explains why the stock is trading at a notable premium c...

2024-07-20 09:20:25 ET Summary VKTX's obesity therapy candidate, VK2735, demonstrates accelerated weight loss results compared to Wegovy/ Mounjaro and the next-gen candidates, including CagriSema/ Zepbound/ Retatrutide. This explains why the stock is trading at a notable premium c...